Cryomass Technologies Stock Today
| CRYM Stock | USD 0.02 0.0003 1.89% |
Performance2 of 100
| Odds Of DistressOver 74
|
Cryomass Technologies is selling at 0.0156 as of the 17th of December 2024; that is 1.89 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0156. Cryomass Technologies has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 17th of November 2024 and ending today, the 17th of December 2024. Click here to learn more.
Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado. The company has 202.53 M outstanding shares. More on Cryomass Technologies
Moving against Cryomass OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cryomass OTC Stock Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Cryomass Technologies [CRYM] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cryomass Technologies's market, we take the total number of its shares issued and multiply it by Cryomass Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cryomass Technologies conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 202.53 M outstanding shares.
Cryomass Technologies currently holds about 2.19 M in cash with (5.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Cryomass Technologies Probability Of Bankruptcy
Ownership AllocationCryomass Technologies holds a total of 202.53 Million outstanding shares. Cryomass Technologies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cryomass Ownership Details
Cryomass Technologies Risk Profiles
| Mean Deviation | 8.9 | |||
| Semi Deviation | 10.33 | |||
| Standard Deviation | 14.11 | |||
| Variance | 199.01 |
Cryomass Stock Against Markets
Picking the right benchmark for Cryomass Technologies otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cryomass Technologies otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cryomass Technologies is critical whether you are bullish or bearish towards Cryomass Technologies at a given time. Please also check how Cryomass Technologies' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cryomass Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Cryomass Technologies Corporate Management
Elected by the shareholders, the Cryomass Technologies' board of directors comprises two types of representatives: Cryomass Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cryomass. The board's role is to monitor Cryomass Technologies' management team and ensure that shareholders' interests are well served. Cryomass Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cryomass Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| BA BA | Chief Officer | Profile | |
| Caroline Lenardon | Consultant | Profile | |
| Ryan Smith | Chief Meds | Profile | |
| Christian Noel | CEO Director | Profile | |
| Janice Matthews | Consultant | Profile | |
| Patricia Kovacevic | Corp Counsel | Profile | |
| Stephen Schroeder | Consultant | Profile |
Other Information on Investing in Cryomass OTC Stock
Cryomass Technologies financial ratios help investors to determine whether Cryomass OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cryomass with respect to the benefits of owning Cryomass Technologies security.